- Home
- SLS vs DH Comparison
SLS vs DH Comparison
Compare SLS & DH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SLS
- DH
- Stock Information
- Founded
- SLS 2012
- DH 2011
- Country
- SLS United States
- DH United States
- Employees
- SLS N/A
- DH N/A
- Industry
- SLS Biotechnology: Pharmaceutical Preparations
- DH Computer Software: Prepackaged Software
- Sector
- SLS Health Care
- DH Technology
- Exchange
- SLS Nasdaq
- DH Nasdaq
- Market Cap
- SLS 238.7M
- DH 283.1M
- IPO Year
- SLS N/A
- DH 2021
- Fundamental
- Price
- SLS $1.51
- DH $2.90
- Analyst Decision
- SLS Strong Buy
- DH Hold
- Analyst Count
- SLS 1
- DH 6
- Target Price
- SLS $7.00
- DH $4.28
- AVG Volume (30 Days)
- SLS 5.3M
- DH 242.0K
- Earning Date
- SLS 11-07-2025
- DH 11-06-2025
- Dividend Yield
- SLS N/A
- DH N/A
- EPS Growth
- SLS N/A
- DH N/A
- EPS
- SLS N/A
- DH N/A
- Revenue
- SLS N/A
- DH $242,275,000.00
- Revenue This Year
- SLS N/A
- DH N/A
- Revenue Next Year
- SLS N/A
- DH $0.68
- P/E Ratio
- SLS N/A
- DH N/A
- Revenue Growth
- SLS N/A
- DH N/A
- 52 Week Low
- SLS $0.77
- DH $2.15
- 52 Week High
- SLS $2.48
- DH $5.68
- Technical
- Relative Strength Index (RSI)
- SLS 32.03
- DH 44.25
- Support Level
- SLS $1.85
- DH $2.60
- Resistance Level
- SLS $2.06
- DH $2.96
- Average True Range (ATR)
- SLS 0.14
- DH 0.15
- MACD
- SLS -0.06
- DH 0.03
- Stochastic Oscillator
- SLS 0.00
- DH 66.67
About SLS SELLAS Life Sciences Group Inc.
SELLAS Life Sciences Group Inc is a late-stage clinical biopharmaceutical company focused on the development of novel therapeutics for a broad range of cancer indications. The company's product candidates currently include galinpepimut-S, or GPS, a peptide immunotherapy directed against the Wilms tumor 1, or WT1, antigen, and GFH009, a selective small molecule cyclin-dependent kinase 9, or CDK9, inhibitor.
About DH Definitive Healthcare Corp.
Definitive Healthcare Corp is a provider of healthcare commercial intelligence. Its SaaS-based healthcare commercial intelligence platform is designed to provide comprehensive and accurate information on the healthcare ecosystem in the U.S. The platform uses deep analytics and data science to help customers develop data-driven strategic decisions, such as finding new markets to enter, building comprehensive go-to-market strategies, accessing tactical information to help target the right decision makers, and improving win rates with detailed contextual information. The company derives substantially all of its revenue from the sale of subscription fees for access to its platform and stand-ready support. Geographically, it derives a majority of its revenue from the United States.